Future medication factory in Mozambique to cost US$6 million

4 March 2011

Maputo, Mozambique, 4 March – Adapting the facilities that will house a medication factory in Mozambique is set to cost US$6 million, US$4.5 million of which will be provided by Brazilian mining company Vale, under the terms of an agreement signed Thursday in Maputo.

The document, signed by the State Shareholdings Management Institute (Igepe) and by Brazilian company Vale and South Africa’s Pro-Air, outlines that within 12 months the latter company will remodel and equip the factory for production of anti-retroviral medication.

Hipólito Hamela, chairman of Igepe, the project’s only shareholder, said that the next step was international certification of the anti-retroviral medication, taking into consideration that they would not only be sold in Mozambique.

The factory is due to start operating at the end of 2012, said Hayne Felipe the director of Farmanguinhos, the state Brazilian laboratory specialised in manufacturing and developing drugs.

The equipment will be donated by Brazil, in line with a pledge made by then President Luiz Inácio Lula da Silva, on his first visit to Mozambique in 2003.

The factory will initially produce 21 different medications whose patents are in the public domain, specifically anti-retroviral drugs and drugs for treatment of diabetes and hypertension, amongst other diseases.

Felipe also said that the factory was expected to produce 300 million pharmaceutical units of anti-retroviral drugs and around 150 million units of other medication. (macauhub)